Supplements
fatty fish decreases inflammation
In plain terms: Does fish help with inflammation or arthritis?
Leans support Supplements 💰 Industry COI noted🔬 Includes disconfirming
Part of: • Fatty fish
RefutedContestedStrong support
consensus score 0.47
Two answers. Eating fish shows a weak, inconsistent link to lower risk of developing rheumatoid arthritis. But concentrated omega-3s (supplement doses) fairly reliably ease RA symptoms - joint tenderness and pain - in people who already have it, even if they don't move inflammation blood tests much.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
5 support 0 contradict 2 tested null 2 mixed · 9 sources, 5 independent groups
What the evidence shows
Leans support, but mostly on a proxy: the counted evidence is observational and largely measures rheumatoid arthritis risk, not inflammation itself. Meta-analyses of cohorts find higher fish intake modestly linked to lower RA risk (RR 0.
The evidence (25)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Asoudeh F, Jayedi A, Kavian Z, Ebrahimi-Mousavi S, Nielsen SM, Mohammadi H 2021 · Adv Nutr | meta-analysis | supports | moderate | SR+dose-response meta 13 studies: highest vs lowest fish inversely associated with RA risk (RR 0.89). |
| Kęska M, Kęska M, Perliński M, Pabich P, Onichimowski D 2026 · Nutrients | observational | supports | low | Narrative review of fish-oil-containing lipid emulsions in parenteral nutrition for critically ill patients; cites meta-analyses/trials suggesting reduced infection/sepsis risk and improved outcomes via immunomodulatory, pro-resolving media |
| Tedeschi SK, Bathon JM, Giles JT, Lin TC, Yoshida K, Solomon DH 2018 · Arthritis Care Res | observational | supports | low | Cross-sectional RA cohort: fish >=2x/week associated with lower disease activity (DAS28-CRP). |
| Xu B, Liang D, Chen G 2025 · Food Sci Nutr | meta-analysis | supports | moderate | MA of 24 RCTs in RA (14 fatty-acid trials, 725 participants). Exposure was supplements: 'fish oil capsules, liquid nutritional supplements ... n‐3 PUFA capsules, cod liver oil capsules, or omega‐3 fatty acid capsules' (plus CLA and GLA capsules). DAS28 'MD −0.20, −0.39 to 0.00, p = 0.05, I 2 = 80%' (9 studies); TJC 'MD −2.51, −3.72 to −1.31'; SJC, PGA, VAS not significant. Asymmetric funnel plot. Supplement exposure, not fish as food - off-scope. |
| Di Giuseppe D, Crippa A, Orsini N, Wolk A 2014 · Arthritis Res Ther | meta-analysis | tested-null | moderate | Dose-response meta 7 studies: non-significant inverse (RR 0.96/serving); stronger inverse at 1-3 servings/wk (RR 0.76). |
| Nguyen Y, Salliot C, Gelot A, Gambaretti J, Mariette X, Boutron-Ruault MC, Seror R 2020 · Nutrients | observational | mixed | moderate | E3N-EPIC: MedDiet (incl fish) not associated with RA overall; protective only among ever-smokers. |
| Jurek JM, Zablocka-Slowinska K, Pieczynska J, Lipert A, Clavero-Mestres H, Auguet T 2026 · Nutrients | meta-analysis | supports | moderate | Systematic review of 7 MASLD RCTs (2020-2026) with narrative synthesis: 'No meta-analysis was performed due to the limited evidence base (seven RCTs)'. Fish-oil/omega-3 capsule trials reported no inflammatory markers (Table 10 N/A). Only inflammation signal: one 34-patient trial of freshwater carp (~344 g/d, lean fish) vs fish plus red meat, IL-6 lower (p = 0.001). No pooled data of its own and off-exposure for fatty fish - review, zero weight. |
| Al-Muzafar HM, Amin KA 2026 · Int J Prev Med | animal | supports | moderate | Rat hypercholesterolaemia model, 8 weeks: 'Fish oil was given as a capsule at a dose of 100 mg/kg body weight (BWt).' HCD raised TNF and CRP and 'These changes were ameliorated with the administration of atorvastatin and fish oil.' No estimates in abstract; methods say 'Eighty rats ... divided into five equal groups' but describe four. Capsule in rats, not fish as food - off-scope. |
| Chataigner M, Peltier A, Bouvret E, Dinel AL, Joffre C, Pallet V 2026 · Am J Clin Nutr | RCT | supports | moderate | Double-blind RCT, 53 healthy adults 60-73 y, 3 months: 'FH [1 g of low-molecular-weight peptides and 30 mg n-3 (ω-3) long-chain polyunsaturated fatty acids (PUFAs)] or placebo daily'. Secondary: 'reduced serum C-reactive protein levels (P = 0.038; β = -0.33; CI: -0.63, -0.02) and inflammation status score (P = 0.046; β = -0.35; CI: -0.69, -0.01)'. Two authors funded by Abyss Ingredients. Supplement exposure, not fish as food - off-scope. |
| Wang R, Goruk S, Chan CB, Field CJ 2026 · J Nutr Biochem | animal | mixed | moderate | Wistar rats (age wk 3-10) on high-fat chow with '0% docosahexaenoic acid (DHA)+0% arachidonic acid (ARA) (control), 1% DHA+1% ARA (1% DHA), 2% DHA+1% ARA (2% DHA) or 1% DHA+1% ARA+1% eicosapentaenoic acid (EPA) (fish oil)'. Plasma: 'experimental diets lowered IL-8 (1%DHA, male-only), CRP (2%DHA) and TGF-β (2%DHA, female-only) (P < .02)'; MLN IL-10 fell and IL-8 rose in some arms. Isolated LCPUFA in rat chow, not fish as food - off-scope. |
| Dimopoulou M, Madesis P, Dimopoulou A, Gortzi O 2026 · Foods (Basel, Switzerland) | observational | supports | low | Systematic review (PubMed/Web of Science/Scopus/Cochrane through Nov 2025) explicitly aimed at omega-3 PUFA's potential to reduce inflammatory markers; concludes higher PUFA intake in older adults associates with better cardiovascular/cogni |
| Dimopoulou M, Savvidi S, Madesis P, Dimopoulou A, Stagos D, Gortzi O 2026 · Marine drugs | observational | supports | low | Narrative review of omega-3 marine supplements/enhanced foods in children; states omega-3 fatty acids 'exhibit anti-inflammatory properties' and may improve metabolic health, though effects on outcomes are described as mixed/inconsistent. |
| Nguyen Y, Salliot C, Mariette X, Boutron-Ruault MC, Seror R 2022 · Arthritis Care Res | observational | mixed | moderate | E3N cohort: no linear association; moderate fish consumption (tertile 2) HR 0.74 for RA. |
| Hong K, Hun M, Wu F, Mao J, Wang Y, Zhu J, Zhou X, Xie H, Tian J, Wen C 2024 · Autoimmun Rev | meta-analysis | mixed | moderate | Umbrella review of syntheses plus MR, exposure omega-3 fatty acids (not fatty fish): 'The umbrella review identified 21 studies (8 systematic reviews and 13 meta-analyses)'. The inflammation finding is re-passed from those reviews: 'in our summary review, omega-3 fatty acids can improve disease activity and inflammation biomarkers'. The paper's own MR data measure autoimmune-disease risk, not inflammation. Review layer - zero weight. |
| Di Giuseppe D, Wallin A, Bottai M, Askling J, Wolk A 2014 · Ann Rheum Dis | observational | supports | moderate | Swedish Mammography Cohort: long-chain n-3 >0.21 g/d associated with 52% decreased RA risk. |
| Giorgini G, Leblanc N, Muller C, Dumais E, Labbé-Blondeau MN, Thibodeau A, Flamand N, Di Marzo V, Silvestri C 2026 · Sci Rep | animal | supports | moderate | DSS-colitis mice (n = 8/group): 'Fish oil from tuna (FO; 50mgday- 52uL/day ...), seal oil (SO; ...) were administered ... by daily gavage'. 'While neither FO or SO counteracted DSS-induced loss of weight, SO mitigated the increase in intestinal permeability and was more efficacious at reducing inflammation markers ( Il1b , Il6 , Tnfa and Arg1 ) than FO.' Seal oil supplier Silicycle part-funded. Isolated oil by gavage in mice, not fish as food - off-scope. |
| Rodziewicz A, Bryl E 2026 · Nutrients | observational | supports | low | Narrative review of diet and microbiome in rheumatoid arthritis; identifies fish consumption and fish oil (EPA/DHA) among the most-researched dietary interventions shown to influence RA disease activity and inflammatory status. |
| Gkiouras K, Grammatikopoulou MG, Myrogiannis I, Papamitsou T, Rigopoulou EI, Sakkas LI, Bogdanos DP 2022 · Crit Rev Food Sci Nutr | meta-analysis | mixed | moderate | Meta-analysis of 23 placebo-controlled RCTs (PROSPERO CRD42019137041) 'comparing n-3 supplements to placebo' in RA: pain SMD -0.16 (95% CI -0.40 to 0.09), tender joints SMD -0.20 (-0.46 to 0.05), swollen joints SMD -0.10 (-0.28 to 0.07); 'c-reactive protein was reduced only by 0.21 mg/dL (95% CI: -0.75 to 0.33)'. Certainty 'mostly of 'very low/low' quality'. Supplement exposure, not fish as food - off-scope, as with Xu 2025 and Sigaux 2022. |
| Patterson GE, Osorio EY, Dann SM, Melby PC 2026 · J Nutr Sci | animal | supports | moderate | Mouse model of moderate acute malnutrition, 28 days: 'Malnourished mice that had the corn oil in the nutrient-deficient diet replaced with fish oil (MN-FO) had reduced serum inflammatory cytokines (IL-1β, TNF, IL-6, IFNγ, and IL-17A) relative to mice in the MN-CO group'; cytokines shown for 'n = 4–5 mice per group'. Comparator is omega-6 corn oil. Isolated oil in mouse chow, not fish as food - off-scope. |
| Benito-Garcia E, Feskanich D, Hu FB, Mandl LA, Karlson EW 2007 · Arthritis Res Ther | observational | tested-null | high | Nurses' Health Study (82k): no association between fish and RA risk. |
| Alzubi A, Lucchesi A, Burns JL, Cho CE, Ma DWL, Robinson LE, Monk JM 2026 · Marine drugs | observational | supports | low | Narrative review synthesizing mechanistic/clinical trial evidence that long-chain n-3 PUFAs (EPA/DHA) attenuate obesity-associated adipose tissue and skeletal muscle inflammation and inflammatory mediator production. |
| Sigaux J, Mathieu S, Nguyen Y, Sanchez P, Letarouilly JG, Soubrier M, Czernichow S, Flipo RM, Sellam J, Daïen C 2022 · Arthritis Res Ther | meta-analysis | supports | moderate | MA of 30 RCTs (710 supplemented vs 710 controls, mostly RA) of 'oral supplementation with omega (n)-3 and n-6 PUFA'; 'Any marine oil (such as seal oil, microalgae oil) was classified as fish oil'. Disease activity improved (DAS28 SMD −0.36 [−0.60, −0.11]); inflammatory markers split: 'a significant decrease in ESR but not CRP level' (ESR −0.28 [−0.43, −0.13]; CRP −0.08 [−0.53, 0.36], I2 90%). Supplement exposure, not fish as food - off-scope. |
| Dong Y, Greenwood DC, Webster J, Uzokwe C, Tao J, Hardie LJ, Cade JE 2024 · Front Nutr | meta-analysis | supports | low | Dose-response meta 30 studies (~3M): nonlinear inverse association between oily fish intake and RA risk. |
| Curry SA, White MR, Most MS, Grijalva PC, Gibbs RL, Marks-Nelson ES, Schmidt TB, Yates DT 2026 · Metabolites | animal | supports | low | Two lamb heat-stress experiments: 'fish oil capsules twice daily' (1200 mg, n = 11) in study 1 and omega-3 PUFA Ca salts in study 2. Inflammation is cited from the authors' earlier reports on the same animals: TNFa rises 'were fully mitigated by fish oil supplementation throughout the study'. This paper's own outcomes are lipid mobilization and flux. Capsule exposure in livestock, not fish as food - off-scope. |
| Tani S, Suzuki Y, Yagi T, Takahashi A 2026 · Prostaglandins, leukotrienes, and essential fatty acids | observational | supports | moderate | Cross-sectional study of 8675 adults; higher fish intake was significantly associated with lower systemic immune-inflammation index (SII, p<0.0001), with n-3 PUFA intake mediating much of the association. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.